secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImageneBio, Inc. (IMA)
CIK:        0001835579
Form:       8-K
Filed at:   2026-04-13T23:59:59+00:00
Accession:  0001193125-26-151942
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImageneBio raises ~$30M via pre-funded warrants to fund atopic dermatitis and alopecia areata programs
--------------------------------------------------------------------------------

- Gross proceeds of ~$30M from sale of pre-funded warrants for 5.77M shares at $5.199 each.
- Closing expected April 14, 2026; warrants exercisable at $0.001, no expiration.
- Proceeds to fund late-phase development in atopic dermatitis and expand IMG-007 into alopecia areata.
- Registration rights agreement requires filing by early August 2026; cash penalties for delays.
- Beneficial ownership limitation set at 19.99% per investor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835579/000119312526151942/0001193125-26-151942-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835579/000119312526151942/d143873d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-151942

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer